Ignite Creation Date:
2024-05-06 @ 3:55 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04805229
Status:
COMPLETED
Last Update Posted:
2021-03-18
First Post:
2021-03-15
Brief Title:
A Difference-In-Differences Analysis of New Persistent Opioid Use After Surgery
Sponsor:
University of Michigan
Organization:
University of Michigan
Study Overview
Official Title:
Using Difference-in-Differences to Evaluate the Effect of a Statewide Quality Improvement Program on New Persistent Opioid Use After Surgery
Status:
COMPLETED
Status Verified Date:
2020-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The Michigan Opioid Prescribing and Engagement Network M-OPEN was established in 2016 with the goal of reducing excessive opioid prescribing after surgery using evidence-based prescribing guidelines Beginning in July 2016 M-OPEN began a statewide quality improvement campaign to educate providers and share prescribing best practices This retrospective study examines the effect of these efforts on new persistent opioid use after surgery compared to other states where no such program existed using a difference-in-differences approach
Detailed Description:
In the United States surgical care has become a gateway for chronic opioid dependence and its associated morbidity Between 5-10 of patients who receive opioids for postoperative pain control go on to develop long-term opioid use This translates to more than 2 million previously opioid-naïve individuals developing chronic opioid use after surgery each year Persistent opioid use after surgery is associated with increased readmissions healthcare utilization and healthcare expenditures Critically long-term opioid use increases the risk of overdose and death in patients who prior to their surgery had no exposure to opioids
Growing recognition of this problem has led to numerous efforts aimed at reducing opioid-associated morbidity after surgery These include legislative limits on opioid prescribing for acute pain procedure-specific prescribing guidelines based on patient-reported opioid use and opioid-sparing pain management pathways In Michigan specifically the Michigan Opioid Prescribing and Engagement Network M-OPEN led a statewide quality improvement effort beginning in 2016 that focused on provider education using evidence-based opioid prescribing guidelines Previously these guidelines have been shown to significantly reduce excessive postoperative opioid prescribing across the state however it is currently unknown whether these efforts have had any effect on the actual incidence of persistent opioid use after surgery
Therefore the current study will evaluate the incidence of new persistent opioid use before and after the establishment of M-OPEN in Michigan Beginning in 2016 a statewide quality improvement initiative was undertaken in Michigan to improve postoperative opioid prescribing In order to accomplish this goal this study will use a difference-in-differences approach to compare new persistent opioid use in Michigan before and after 2016 to other states where no such quality improvement effort existed
Growing recognition of this problem has led to numerous efforts aimed at reducing opioid-associated morbidity after surgery These include legislative limits on opioid prescribing for acute pain procedure-specific prescribing guidelines based on patient-reported opioid use and opioid-sparing pain management pathways In Michigan specifically the Michigan Opioid Prescribing and Engagement Network M-OPEN led a statewide quality improvement effort beginning in 2016 that focused on provider education using evidence-based opioid prescribing guidelines Previously these guidelines have been shown to significantly reduce excessive postoperative opioid prescribing across the state however it is currently unknown whether these efforts have had any effect on the actual incidence of persistent opioid use after surgery
Therefore the current study will evaluate the incidence of new persistent opioid use before and after the establishment of M-OPEN in Michigan Beginning in 2016 a statewide quality improvement initiative was undertaken in Michigan to improve postoperative opioid prescribing In order to accomplish this goal this study will use a difference-in-differences approach to compare new persistent opioid use in Michigan before and after 2016 to other states where no such quality improvement effort existed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None